Skip to main content
ConductScienceScienceDex

Farhad Parhami

NIH Rank #17200
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6711668Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2024

Linked Award Amount
$889.7K
Full award amounts, FY2024
Award Records
1
Records listing this PI
Award-Linked Rank
#17,200
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Farhad Parhami. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award data coverage

ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.

Single fiscal year on record (FY2024): $889.7K in linked award amounts across 1 award record · Award-linked rank #17200.

FY2024 award records by amount

NIH award records listing Farhad Parhami as a PI. Multi-PI records show the full award amount for context.

  • 5R44DK136405-02R44
    Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
    Max Biopharma, Inc.
    $889.7K
    award amount

Award organization

Organizations that administered FY2024 awards listing Farhad Parhami as a PI.

FY2024 award administered by Max Biopharma, Inc. (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Max Biopharma, Inc.
  2. 2024
    $500K Cumulative Funding

Explore further

Find collaborators for Farhad Parhami

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →
Farhad Parhami | NIH Award Records | ConductScience